Efficacy and Safety Extension Study of Oral Edaravone Administered in Subjects With ALS
Clinical trial NCT05151471 · TERMINATED
Trial details
- NCT number
- NCT05151471
- Sponsor
- Shionogi
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-11
- Primary completion
- 2023-09-29
- Enrollment
- 202
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.